Neither CCR2 nor CCR5 could fulfil that role, indicating the likely requirement for transduction of multiple chemokine receptors into CAR-Ts intended to treat solid tumors, each with its own function along the path from circulation to tumor tissue. Here, CCR2 is linked to neoplasm.